Design And Characterization Of Chitosan Nanoparticles Of Felbinac Using Doe

Authors

  • Sagar Suresh Jadkar
  • Sunil Kumar

DOI:

https://doi.org/10.63682/jns.v14i11S.3079

Keywords:

Chitosan nanoparticles, Felbinac, Design of Experiments (DOE), Entrapment efficiency, Particle size, Drug release, In vitro release, Controlled release, Nanotechnology, NSAID delivery

Abstract

The design and characterization of chitosan nanoparticles loaded with felbinac have been optimized using a Design of Experiments (DOE) approach to improve the drug's therapeutic performance. Felbinac, a nonsteroidal anti-inflammatory drug (NSAID), suffers from poor bioavailability and limited therapeutic efficacy when administered conventionally. Chitosan nanoparticles offer an innovative solution for enhancing solubility, controlled release, and targeted delivery. In this study, various formulations of felbinac-loaded chitosan nanoparticles were prepared and characterized for key parameters, including percentage yield, entrapment efficiency, particle size, and drug release profile. Response surface plots and contour plots were employed to determine the optimal formulation parameters. The formulations exhibited significant variations in entrapment efficiency (63.25%–79.98%) and particle size (75.65–132.87 nm). The optimized formulation (F14) showed excellent drug entrapment efficiency (78.85%) and a small particle size (75.65 nm). The in vitro release studies demonstrated a controlled release profile, with 93.32% of the drug released after 24 hours. The drug release kinetics followed a diffusion-controlled mechanism, as indicated by the Korsmeyer-Peppas model (R² = 0.9836). The findings suggest that chitosan nanoparticles can effectively enhance the bioavailability of felbinac and provide a controlled-release system for sustained therapeutic effects.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Sabbagh, Farzaneh, and Beom Soo Kim. "Recent advances in polymeric transdermal drug delivery systems." Journal of controlled release 341 (2022): 132-146.

Takayama K, Hirose A, Suda I, Miyazaki A, Oguchi M, Onotogi M, Fotopoulos G. Comparison of the anti-inflammatory and analgesic effects in rats of diclofenac-sodium, felbinac and indomethacin patches. International journal of biomedical science: IJBS. 2011 Sep;7(3):222.

Karnam S, Donthi MR, Jindal AB, Paul AT. Recent innovations in topical delivery for management of rheumatoid arthritis: a focus on combination drug delivery. Drug Discovery Today. 2024 Jun 26:104071.

Sharifi-Rad J, Quispe C, Butnariu M, Rotariu LS, Sytar O, Sestito S, Rapposelli S, Akram M, Iqbal M, Krishna A, Kumar NV. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer cell international. 2021 Jun 24;21(1):318.

Mikušová V, Mikuš P. Advances in chitosan-based nanoparticles for drug delivery. International journal of molecular sciences. 2021 Sep 6;22(17):9652.

Luiz MT, Viegas JS, Abriata JP, Viegas F, de Carvalho Vicentini FT, Bentley MV, Chorilli M, Marchetti JM, Tapia-Blacido DR. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. 2021 Aug 1;165:127-48.

Rampado R, Peer D. Design of experiments in the optimization of nanoparticle-based drug delivery systems. Journal of Controlled Release. 2023 Jun 1;358:398-419.

Shirsat AE, Chitlange SS. Application of quality by design approach to optimize process and formulation parameters of rizatriptan loaded chitosan nanoparticles. Journal of advanced pharmaceutical technology & research. 2015 Jul 1;6(3):88-96.

Sharma P, Bhargava S, Parashar D, Mangal A. Formulation and evaluation of nanoparticles containing cyclophosphamide. WJPR. 2017 Nov 3;7(1):785-98.

Nesalin JA, Smith AA. Preparation and evaluation of chitosan nanoparticles containing zidovudine. Asian J Pharm Sci. 2012 Feb 4;7(1):80-4.

Liu J, Gong T, Wang C, Zhong Z, Zhang Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. International journal of pharmaceutics. 2007 Aug 1;340(1-2):153-62.

Samy M, Abd El-Alim SH, Amin A, Ayoub MM. Formulation, characterization and in vitro release study of 5-fluorouracil loaded chitosan nanoparticles. International journal of biological macromolecules. 2020 Aug 1;156:783-91.

Keawchaoon L, Yoksan R. Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles. Colloids and surfaces B: Biointerfaces. 2011 May 1;84(1):163-71.

Downloads

Published

2025-04-05

How to Cite

1.
Suresh Jadkar S, Kumar S. Design And Characterization Of Chitosan Nanoparticles Of Felbinac Using Doe. J Neonatal Surg [Internet]. 2025Apr.5 [cited 2025Oct.2];14(11S):926-33. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/3079